Telisotuzumab Vedotin Approved for NSCLC ...Middle East

News by : (Medscape) -
The antibody-drug conjugate is approved for previously treated advanced NSCLC patients with high c-Met protein overexpression. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Telisotuzumab Vedotin Approved for NSCLC )

Also on site :

Most Viewed News
جديد الاخبار